WATSON 607 (Labetalol 300 mg)
Pill imprint WATSON 607 has been identified as Labetalol hydrochloride 300 mg.
Labetalol is used in the treatment of high blood pressure; hypertensive emergency; pheochromocytoma; postural orthostatic tachycardia syndrome; mitral valve prolapse and belongs to the drug class non-cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Labetalol 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 607 (Labetalol 300 mg)
- 300 mg
- 11.00 mm
- Prescription only
- Drug Class:
- Non-cardioselective beta blockers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide colloidal
pregelatinized corn starch
FD&C Blue No. 2
|NDC Code||Manufacturer / Repackager|
|68084-0457||Amerisource Health Services|
Note: Inactive ingredients may vary.
Labetalol hydrochloride is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...